CD8A and influenza: In fact, many experimental influenza vaccines based on protein-subunits [36,94], peptide epitopes [95,96,97], virus-like particles (VLPs) [98], or DNA [99,100] have demonstrated that the induction of CD8+ T cell responses cross-protects against heterologous viral challenge in small animal models.